SHANGHAI, China--(BUSINESS WIRE)--Medicilon/MPI Preclinical Research-Shanghai is pleased to announce the Grand Opening of its new preclinical research facility. The two parent companies, Shanghai Medicilon and MPI Research, are equally represented in this new joint venture. The 50,000 square foot building is located in the Chuansha Economic Park in Shanghai, China. This new facility will meet the regulatory standards set forth by the US FDA and other regulatory agencies worldwide.
